Drug Testing with Tiny Ball of Cells: What Can Go Wrong?
Mon Sep 22 2025
Drug testing is getting a upgrade. Scientists are using tiny balls of cells, called spheroids, to test new medicines. These spheroids are better than flat cell cultures because they act more like real tissues in the body. But, there are some problems that can mess up the results.
First, how these spheroids are made can make a big difference. There are different ways to create them, and each method has its own pros and cons. Some methods are more precise, while others are easier to do. The choice of method can affect how well the drugs work in the test.
Next, size matters. Spheroids can vary in size, and this can change how the cells respond to drugs. Things like how fast the cells grow, how they die, and how they change over time can all affect the size of the spheroid. Bigger spheroids might not let drugs penetrate as well, making it seem like the drug isn't working as well as it should.
Lastly, not all cells in a spheroid are alive and well. The center of the spheroid can become low in oxygen, which can kill some cells. This can make it harder to tell if a drug is toxic or not. Also, some cells might detach and die, which can also affect the results.
To make drug testing with spheroids more reliable, scientists need to consider these factors. By understanding and controlling these variables, they can get more accurate results. This way, they can develop better and safer drugs.
https://localnews.ai/article/drug-testing-with-tiny-ball-of-cells-what-can-go-wrong-20f7fc21
continue reading...
questions
What are the primary biological factors contributing to size variation in spheroids, and how do they influence drug efficacy assessments?
Could the development of hypoxic cores in spheroids be a deliberate mechanism to skew toxicity assessments?
Could the variability in spheroid-based drug screening be intentionally introduced to manipulate research outcomes?
actions
flag content